- Stocks
- Healthcare
- NASDAQ: BRKR

Price (delayed)

$77.32

Market cap

$11.35B

P/E Ratio

38.66

Dividend/share

$0.2

EPS

$2

Enterprise value

$11.95B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions

BRKR's equity is up by 19% QoQ and by 4% YoY

BRKR's EPS is up by 9% year-on-year and by 9% since the previous quarter

BRKR's price to earnings (P/E) is 17% higher than its last 4 quarters average of 33.0 but 4.8% lower than its 5-year quarterly average of 40.6

Bruker's debt has decreased by 9% YoY but it has increased by 9% from the previous quarter

The quick ratio has decreased by 28% YoY

What are the main financial stats of BRKR

Market
Valuations
Earnings

Shares outstanding

146.73M

Market cap

$11.35B

Enterprise value

$11.95B

Price to earnings (P/E)

38.66

Price to book (P/B)

10.21

Price to sales (P/S)

4.54

EV/EBIT

28.94

EV/EBITDA

23.82

EV/Sales

4.72

Revenue

$2.53B

EBIT

$413M

EBITDA

$501.8M

Free cash flow

$159.1M

Per share
Balance sheet
Liquidity

EPS

$2

Free cash flow per share

$1.07

Book value per share

$7.57

Revenue per share

$17.03

TBVPS

$19.4

Total assets

$3.61B

Total liabilities

$2.49B

Debt

$1.25B

Equity

$1.11B

Working capital

$1.2B

Debt to equity

1.13

Current ratio

2.31

Quick ratio

1.22

Net debt/EBITDA

1.21

Margins
Efficiency
Dividend

EBITDA margin

19.8%

Gross margin

51.6%

Net margin

11.7%

Operating margin

17.1%

Return on assets

8.5%

Return on equity

29.4%

Return on invested capital

16.8%

Return on capital employed

15.3%

Return on sales

16.3%

Dividend yield

0.26%

DPS

$0.2

Payout ratio

10%

How has the Bruker stock price performed over time

Intraday

1.44%

1 week

4.2%

1 month

12.19%

1 year

13.41%

YTD

13.12%

QTD

13.12%

How have Bruker's revenue and profit performed over time

Revenue

$2.53B

Gross profit

$1.31B

Operating income

$432.7M

Net income

$296.6M

Gross margin

51.6%

Net margin

11.7%

BRKR's gross profit is up by 8% year-on-year

The net income is up by 8% since the previous quarter and by 7% year-on-year

Bruker's net margin has increased by 6% from the previous quarter

BRKR's operating income is up by 4.7% year-on-year

What is Bruker's growth rate over time

What is Bruker stock price valuation

P/E

38.66

P/B

10.21

P/S

4.54

EV/EBIT

28.94

EV/EBITDA

23.82

EV/Sales

4.72

BRKR's price to earnings (P/E) is 17% higher than its last 4 quarters average of 33.0 but 4.8% lower than its 5-year quarterly average of 40.6

BRKR's EPS is up by 9% year-on-year and by 9% since the previous quarter

The stock's price to book (P/B) is 25% more than its 5-year quarterly average of 8.2 and 11% more than its last 4 quarters average of 9.2

BRKR's equity is up by 19% QoQ and by 4% YoY

The stock's price to sales (P/S) is 26% more than its 5-year quarterly average of 3.6 and 23% more than its last 4 quarters average of 3.7

Bruker's revenue has increased by 4.7% YoY

How efficient is Bruker business performance

Bruker's return on invested capital has decreased by 15% YoY

Bruker's return on equity has increased by 9% YoY and by 7% QoQ

BRKR's return on assets is up by 8% since the previous quarter

What is BRKR's dividend history

DPS

$0.2

Dividend yield

0.26%

Payout ratio

10%

Recent dividends

How did Bruker financials performed over time

BRKR's total assets is 45% greater than its total liabilities

The quick ratio has decreased by 28% YoY

BRKR's current ratio is down by 12% year-on-year and by 2.1% since the previous quarter

Bruker's debt is 13% more than its equity

BRKR's equity is up by 19% QoQ and by 4% YoY

BRKR's debt to equity is down by 12% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.